Quarterly report pursuant to Section 13 or 15(d)

3. Summary of Significant Accounting Policies (Tables)

v3.19.3
3. Summary of Significant Accounting Policies (Tables)
6 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of antidilutive shares
    September 30,  
    2019     2018  
Common stock to be issued upon vesting of restricted stock units     2,000       4,000  
Common stock to be issued upon exercise of options     136,000       169,000  
Common stock to be issued upon exercise of warrants     446,000       153,000  
Common stock to be issued upon exercise of common stock units (1)     46,000        
      630,000       326,000  
Disaggregated Revenue by Source
   

Three Months Ended

September 30,

   

Six Months Ended

September 30,

 
    2019     2018     2019     2018  
Product                        
Human Skin Care   $ 3,800,000     $ 4,074,000     $ 7,762,000     $ 7,628,000  
Animal Skin Care     912,000       561,000       1,335,000       1,102,000  
      4,712,000       4,635,000       9,097,000       8,730,000  
Service     256,000       304,000       582,000       578,000  
Total   $ 4,968,000     $ 4,939,000     $ 9,679,000     $ 9,308,000